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Invited Editorial

From ‘Made in India’ to ‘Make in India’ in Pharmaceuticals
S K Kulkarni
One of the ambitious projects of our Prime Minister
Mr Narendra Modi is ‘Make in India”. It is not just
a slogan or change of nomenclature from ‘Made
in India’ to ‘Make in India’. But the very idea of
‘Make in India’ is the change of mindset of creating
something of our own, a proud desire of owning
our own research outcome namely, the product
(discovering a new medicine entirely based on
Indian research). Even though we proudly say that
‘every third pill’ consumed on this planet is ‘Made in
India’ and more than 40% of the generic medicines
prescribed in the USA are ‘Made in India’, ‘How
and/or when the next new molecule would come
out of Indian research (Make in India)?’ is a million
dollar question.
From ‘Made in India’ to ‘Make in India’ in
Pharmaceuticals– a daunting task
The research output of Indian Universities is rarely
commercialized and if one goes by the reports
in the lay press, only 2 per cent of the work done
for PhD research of a premier University in the
last one decade has been published in international
peer-reviewed journals. Addressing the 98th Indian
Science Congress in January 2011, former Prime
Minister of India observed that even though Sir C V
Raman discovered his Nobel Prize winning, Raman
Effect some 80 years ago, the instruments available
in India using his principle are imported.
Unfortunately, the linkages among Universities,
research laboratories, and industry are not
harnessed to yield meaningful outcomes to benefit
our society. There is an urgent need to build a
credible Pharmaceutical eco-system in question, in our
S K Kulkarni

Emeritus Professor of Pharmacology & Former Pro-Vice
Chancellor (DUI), Panjab University, Chandigarh.
Email: skkulkarni46@gmail.com

institutions and Universities. We must take a leaf
out of the experiences of the Western Universities
and institutions and create a healthy and competitive
environment so that future generations of
professionals become products of pharmaceutical
innovation eco-system. With mushrooming of
institutions, it is a tough call but a beginning has to
be made before it is too late.
Professor E Roberts, School of Management and
Entrepreneurship of Massachusetts Institute of
Technology (MIT), USA describes about ‘research
with consequences’ as innovations that generate
value (Innovation= invention + commercialization).
In other words, successful research results in
innovation. With this approach, MIT boasts as one
of the most prolific innovation factories the world
has seen. The revenues generated by the companies
created and the people employed by the MIT alumni,
is one of the largest economies in the world.
Thus, Innovation eco-system is an integrated approach
for development. Innovation is something that
generates value. Innovators must be challenged to
produce solutions (medicines) that our society needs.
Innovative solutions or research with consequences
(research bearing fruits) with potentials must be
nurtured and rapidly applied. Inventions will become
innovations when they produce consequences
(fruits/medicines) of human use. There are two
key elements for building a successful eco-system.
The first and the foremost is the ‘innovation
culture’, having people who can make a difference
or role models in the system. Secondly, people with
entrepreneurial capability. These individuals would
build networking both for exchange of knowledge
(ideas) and business.
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